• The Joint Corp. posted first-quarter revenue of $14.8 million, up 13%, while net income rose 34% to $1.3 million.
• System-wide sales fell 4.9% to $126.1 million, while comp sales declined 4.2%.
• Adjusted EBITDA increased 22% to $3.5 million; operating cash flow improved to $(1.5) million, while free cash flow improved to $(1.7) million.
• Clinic count slipped to 943 from 960 at year-end, reflecting three openings and 20 closures; it also agreed to sell 45 company-owned or managed clinics in Southern California for $2.3 million as it moves toward a near pure-play franchisor model.
• Repurchased 137,000 shares for $1.1 million at an average $8.35, while reiterating 2026 guidance for system-wide sales of $519 million-$552 million and consolidated adjusted EBITDA of $12.5 million-$13.5 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Joint Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001612630-26-000048), on May 07, 2026, and is solely responsible for the information contained therein.